MAY 11, 2016 6:51 AM PDT

The Role of Insufficient SHANK3 in Autism

WRITTEN BY: Cassidy Reich
Autism is a mystery because it has been very difficult to narrow down what causes this complex and varied pathology. Mutations in various genes have been implicated as risk factors and one such gene is Shank3. The SHANK3 protein is a scaffold protein that is expressed ubiquitously, but is heavily enriched in the postsynaptic densities of excitatory synapses. Deletion of Shank3 is thought to be one of the principal causes of Phelan-McDermid syndrome. Phelan-McDermid syndrome (PMS) is a genetic disorder caused by the deletion of a portion of chromosome 22, where the Shank3 locus is. The main symptoms of PMS are thought to be a result of Shank3 deletion and include developmental delay, intellectual disability, and absent or delayed speech. PMS patients can also exhibit autistic-like behavior such as limited eye contact, adding to the support for SHANK3’s involvement in autism spectrum disorders (ASD).

It is possible that loss of SHANK3 function causes these impairments simply through impaired synaptic function, but some of the cellular changes in Shank3-mutant neurons challenge this explanation. A recent paper by first authors Fei Yi and Tamas Danko from Stanford published in Science details the cellular mechanism behind the mutant Shank3 phenotype. Using neurons derived from human embryonic stem cells with a Shank3 conditional knockout, the researchers saw that insufficient SHANK3 led to a wide variety of cellular changes, including synaptic deficits and altered electrical properties. The question then becomes how does loss of a postsynaptic scaffolding protein lead to changes in the intrinsic electrical properties of the neuron?

The main electrical property change that they saw was a huge increase in input resistance. In this context, the increased input resistance makes the neurons more excitable in response to the same amount of current. From this observation, they hypothesized that altered channel conductance is the primary impairment caused by insufficient SHANK3. What they found is that insufficient SHANK3 protein causes a huge impairment in a particular cation current called IH. The IH current goes through particular channels called HCN channels and it is a particularly interesting current because it is activated by hyperpolarization. The resting potential of a neuronal membrane is ~ -70mV and the neuron fires when the membrane is depolarized to ~ 35mV. Hyperpolarization is when the membrane potential is even more negative. At this potential, the IH current lets cations (positively charged ions) into the neuron to depolarize the membrane back to its resting potential. Because of this functionality, HCN channels and IH currents are known as “pacemakers”; they help to establish rhythmic or oscillatory firing in neurons. HCN channels may also play a role in synaptic plasticity. Pharmacological blockade of IH currents mimics the cellular phenotype of insufficient SHANK3, confirming that the changes in neuronal electrical properties is the primary cellular phenotype caused by SHANK3 insufficiency. The other cellular changes (impaired synaptic transmission, deficits in dendritic branching, and increased excitability) are caused by the impaired IH current. These changes were rescued by re-expression of functional SHANK3.
 

It is important to figure out the cellular changes caused by SHANK3 insufficiency because it is a gene that has been heavily linked to autism. The research presented in this Science paper, apart from being super interesting, could eventually lead to a pharmacological target to relieve some of the symptoms of PMS and ASD.     

Sources: Science, PMS, and HCN review
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
DEC 04, 2019
Neuroscience
DEC 04, 2019
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
IV Treatment for Traumatic Brain Injury
Scientists are now using exosomes intravenously as a method of cell-to-cell technology for treating patients with traumatic brain injury (TBI). They discov...
DEC 31, 2019
Neuroscience
DEC 31, 2019
How PTSD Develops in the Mind
Close 1 in 4 people who experience severe trauma develop Post Traumatic Stress Disorder (PTSD). Now, a recent study has identified how these traumatic expe...
JAN 05, 2020
Neuroscience
JAN 05, 2020
Memory Recall Linked to Circadian Rhythm
  A study from the University of Tokyo identified a specific gene responsible for memory retrieval in mice. The study aimed to investigate the biology...
JAN 09, 2020
Neuroscience
JAN 09, 2020
Why Do you Have a Higher IQ than your Grandparents?
In the 1980’s James Flynn found that on average, human intelligence quotients (IQ) increase by 3 points every 10 years. Known as the “Flynn eff...
FEB 23, 2020
Drug Discovery & Development
FEB 23, 2020
Drug Preserves Brain Cells
Can we preserve brain cells even after years of hopeless research? Apparently, yes—according to a recent study published in the Lancet treating patie...
Loading Comments...